Wikidata

(Q63811841)

English

Evaluation of the Onset of Action in Highly Active Multiple Sclerosis (MS)

clinical trial

In more languages

Statements

title
A 2-year Prospective Study to Evaluate the Onset of Action of Mavenclad® in Subjects With Highly Active Relapsing Multiple Sclerosis (English)
0 references
medical condition
sclerosis
0 references
multiple sclerosis
0 references
country
Australia
0 references
Austria
0 references
Belgium
0 references
Canada
0 references
Finland
0 references
France
0 references
Germany
0 references
Hungary
0 references
Israel
0 references
Italy
0 references
Poland
0 references
Spain
0 references
Sweden
0 references
United Kingdom
0 references
start time
28 May 2018
0 references
end time
1 July 2020
0 references
number of participants
300
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q63811841&oldid=1857379529"